PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 175 filers reported holding PRECIGEN INC in Q1 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $236,188 | +53.4% | 155,387 | +112.3% | 0.00% | +100.0% |
| Q3 2022 | $154,000 | +710.5% | 73,206 | +404.9% | 0.00% | – |
| Q2 2022 | $19,000 | -51.3% | 14,500 | -22.5% | 0.00% | – |
| Q1 2022 | $39,000 | -92.7% | 18,700 | -86.9% | 0.00% | -100.0% |
| Q4 2021 | $531,000 | -25.6% | 143,200 | +0.1% | 0.01% | -16.7% |
| Q3 2021 | $714,000 | -34.8% | 143,100 | -14.8% | 0.01% | -25.0% |
| Q2 2021 | $1,095,000 | -5.4% | 168,000 | 0.0% | 0.01% | -20.0% |
| Q1 2021 | $1,157,000 | -40.8% | 168,000 | -12.3% | 0.01% | -28.6% |
| Q4 2020 | $1,953,000 | +232.7% | 191,500 | +14.1% | 0.01% | +180.0% |
| Q3 2020 | $587,000 | -7.1% | 167,800 | +32.3% | 0.01% | -16.7% |
| Q2 2020 | $632,000 | +35.3% | 126,800 | -7.8% | 0.01% | -14.3% |
| Q1 2020 | $467,000 | – | 137,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |